Bank of America’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-5,576
Closed -$592K 8501
2014
Q2
$592K Sell
5,576
-9,412
-63% -$923K ﹤0.01% 4446
2014
Q1
$1.3M Buy
14,988
+13,967
+1,368% +$1.08M ﹤0.01% 3629
2013
Q4
$43K Buy
1,021
+207
+25% +$8.51K ﹤0.01% 6661
2013
Q3
$36K Sell
814
-3,591
-82% -$149K ﹤0.01% 6615
2013
Q2
$150K Buy
+4,405
New +$155K ﹤0.01% 5883

Bank of America's FURX Position: Q3 2014 in Review

Bank of America sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q3 2014, closing a stake of 5,576 shares — an estimated $592K sold.

Bank of America first reported a position in FURX in Q2 2013 and held it in 5 quarters. The position peaked at $1.3M in Q1 2014. 0 funds tracked by Wall St. Rank hold FURX as of Q3 2014.

  • Bank of America reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Bank of America sold 5,576 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q3 2014, an estimated $592K.
  • Bank of America first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 5 quarters.
  • Bank of America's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.3M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q3 2014.

Based on Bank of America's 13F filing for Q3 2014, filed 14 Nov 2014.